Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Promising phase II results for thalidomide in brain cancer and Kaposi's sarcoma

May 23, 1997

Improved microtubule-inhibitory anticancer agents in development

May 23, 1997

NeoPharm reports on antisense liposomes which inhibit Raf-1 proteins

May 23, 1997

Oxford GlycoSciences receives U.K. approval to commence trials on novel nucleoside analogue

May 22, 1997

Enrollment complete for phase II trial of lisofylline in AML

May 22, 1997

Phase I results with Isis antisense anticancer drug reported at ASCO

May 22, 1997

Pharmacyclics reports phase I results for Lu-Tex

May 22, 1997

Interim results with Pharmacyclics' Gd-Tex reported at ASCO

May 22, 1997

Encouraging results reported for ImClone's lead cancer therapeutic agent

May 22, 1997

Onyx reports clinical results of anticancer viral therapeutic at ASCO meeting

May 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026